Alzheimers Research & Therapy

SCI SCIE

国际简称：ALZHEIMERS RES THER 参考译名：阿尔茨海默病研究与治疗

主要研究方向：医学-神经病学非预警期刊审稿周期：>12周，或约稿

《阿尔茨海默病研究与治疗》(Alzheimers Research & Therapy)是一本由BioMed Central出版的以医学-神经病学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

1区中科院分区
Q1 JCR分区
281 年发文量
8.9 IF影响因子
开放是否OA
53 H-index
2009 创刊年份
1 issue/year 出版周期
English 出版语言

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease and the leading open access journal in the field. Affiliated to Alzheimer's Disease International (ADI), it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports. Although the primary focus is Alzheimer's dementia, the scope encompasses translational research into other neurodegenerative diseases.

[ 查看全部 ]

投稿咨询加急咨询

Alzheimers Research & Therapy期刊信息

ISSN：1758-9193
出版语言：English
是否OA：开放
E-ISSN：1758-9193
出版地区：United Kingdom
是否预警：否
出版商：BioMed Central
出版周期：1 issue/year
创刊时间：2009
开源占比：0.9982
Gold OA文章占比：99.87%
OA被引用占比：1
出版国人文章占比：0.04
出版撤稿占比：0
研究类文章占比：95.37%

Alzheimers Research & Therapy CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

12.8

2.479

1.807

学科类别	分区	排名	百分位
大类：Neuroscience 小类：Cognitive Neuroscience	Q1	5 / 129	96%
大类：Neuroscience 小类：Neurology	Q1	9 / 201	95%
大类：Neuroscience 小类：Neurology (clinical)	Q1	21 / 403	94%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Alzheimers Research & Therapy中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	CLINICAL NEUROLOGY 临床神经病学 NEUROSCIENCES 神经科学	1区 1区

Alzheimers Research & Therapy JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CLINICAL NEUROLOGY	SCIE	Q1	13 / 296	95.8
学科：NEUROSCIENCES	SCIE	Q1	18 / 330	94.7
学科：CLINICAL NEUROLOGY	SCIE	Q1	11 / 296	96.45
学科：NEUROSCIENCES	SCIE	Q1	12 / 330	96.52

Alzheimers Research & Therapy历年数据统计

影响因子

中科院分区

Alzheimers Research & Therapy中国学者发文选摘

1、Diagnostic performance of plasma GFAP in preclinical stages of Alzheimer's disease using the Lumipulse platfor
Author: Valera-Barrero, Andrea; Martinez-Dubarbie, Francisco; Guerra, Armando; Lopez-Garcia, Sara; Lage, Carmen; Rivera-Sanchez, Maria; Pozueta-Cantudo, Ana; Garcia-Martinez, Maria; Corrales-Pardo, Andrea; Bravo, Maria; Lopez-Hoyos, Marcos; Irure-Ventura, Juan; Cahuana-Santamaria, Heidy; Garcia-Unzueta, Maria Teresa; Di Molfetta, Guglielmo; Blennow, Kaj; Ashton, Nicholas J.; Zetterberg, Henrik; Sanchez-Juan, Pascual; Rodriguez-Rodriguez, Eloy; Fernandez-Matarrubia, Marta

Journal: ALZHEIMERS RESEARCH & THERAPY. 2026; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13195-026-02012-9
2、Improved polygenic risk prediction for alzheimer's disease and related dementias using deep learning: age and APOE-stratified analysi
Author: Mostafaei, Shayan; Shemer, Daniel Wikström; Mak, Jonathan K. L.; Karlsson, Ida K.; Hägg, Sara

Journal: ALZHEIMERS RESEARCH & THERAPY. 2026; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13195-026-02011-w
3、Association of functional brain alterations with β-amyloid, tau, and cognitive decline in Alzheimer's diseas
Author: Guo, Wanwan; Shao, Hongda; Zhang, Yan; Liu, Lin; Zheng, Hairong; Liang, Dong; Liu, Jianjun; Zhang, Lingyan; Hu, Zhanli

Journal: ALZHEIMERS RESEARCH & THERAPY. 2026; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13195-026-01991-z
4、Upregulation of SLC38A2 by melatonin attenuates hippocampal ferroptosis in Alzheimer's diseas
Author: Lv, Lifang; Jia, Yuhan; Zhang, Chi; Gao, Qiang; Han, Huiming; Li, Jiaxin; Cai, Zhenhua; Liu, Meiqi; Zhang, Ying; Liu, Jinfeng; Zhu, Hui

Journal: ALZHEIMERS RESEARCH & THERAPY. 2026; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13195-026-01990-0
5、Akkermansia muciniphila reduces neuroinflammation and Aβ deposition via tryptophan metabolism in the APP/PS1 mouse model of Alzheimer's diseas
Author: Wang, Binghua; Pan, Miaomiao; Yang, Liu; Xu, Jietian; Ye, Chang; Li, Yunhan; Gong, Qianyi; Liu, Changqian; Li, Lanfang; Qin, Jie; Ren, Dayong; Zhao, Chao; Liang, Chunmin

Journal: ALZHEIMERS RESEARCH & THERAPY. 2026; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13195-025-01880-x
6、Associations of white matter hyperintensity regression and progression with cognitive and structural brain changes: a population-based cohort stud
Author: Zhang, Jiajia; Jia, Xuejia; Li, Haibin; Jia, Xiuqin; Yang, Qi

Journal: ALZHEIMERS RESEARCH & THERAPY. 2026; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13195-026-01971-3
7、Plasma ATN biomarkers across the alzheimer's disease continuum in a Chilean community- and clinic-based cohor
Author: Orellana, Paulina; Henriquez, Fernando; Cabral-Miranda, Felipe; Hernandez, Hernan; Ferreira, Pamela C. L.; Bellaver, Bruna; Caviedes, Ariel; Pizarro, Matias; Gonzalez-Silva, Carolina; Marin-Diaz, Nickole; Riquelme, Patricio; Pozo, Natalia; Damm, Francisca; Court, Felipe A.; Gonzalez-Billault, Christian; Lillo, Patricia; Thumala-Dockendorff, Daniela; Cerda, Mauricio; Villagra, Roque; De La Cruz, Rolando; Karikari, Thomas; Ibanez, Agustin; Zetterberg, Henrik; A Pascoal, Tharick; Duran-Aniotz, Claudia; Slachevsky, Andrea

Journal: ALZHEIMERS RESEARCH & THERAPY. 2026; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13195-026-01974-0
8、Aerobic exercise facilitates p300 nuclear translocation via ADRB2-AMPKα signaling, leading to enhanced histone acetylation and mitigation of cognitive decline in APP/PS1 mic
Author: Chai, Gao-shang; Gao, Tian-long; Bi, Shu-guang; Mao, Yu-ming; Yang, Liu; Wang, Fang-zhou; Chen, Jia; Wu, Jia-jun; Gong, Juan; Geng, Shan; Yuan, Jia-qi; Zhang, Ke-yu; Yi, Hai-yan; Lan, Zi-chong; Nie, Yun-juan; Yu, Haitao

Journal: ALZHEIMERS RESEARCH & THERAPY. 2026; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13195-026-01983-z